secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001193125-24-084096
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics CFO Erin Colgan resigns effective April 10, 2024
-----------------------------------------------------------------------

- Erin Colgan resigns as CFO and all positions, effective April 10, 2024.
- Resignation is voluntary and not due to any disagreement with the company.
- No successor has been announced; transition details are not provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524084096/0001193125-24-084096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524084096/d821191d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-084096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer